C2C_ASC

N/A

Report date: 2025/01/26 16:55:38

Base Information

Drug NameC2C_ASC

Drug Alias Nameallogeneic adipose-derived mesenchymal stromal/stem cell therapy (Cell2Cure)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsDiabetic Foot

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCell2Cure APS

China Registration ClassN/A

Develop Information

Active CompaniesCell2Cure APS

Inactive CompaniesN/A

Active IndicationsDiabetic Foot

Inactive IndicationsN/A

Other Information

ATC CodeN/A